Haemonetics Corporation (HAE)
Quick ratio
| Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 306,763 | 320,846 | 299,283 | 344,429 | 178,800 | 193,978 | 351,005 | 285,719 | 284,466 | 224,002 | 241,200 | 214,948 | 259,496 | 236,877 | 192,420 | 173,462 | 192,305 | 189,002 | 279,169 | 275,725 |
| Short-term investments | US$ in thousands | — | — | — | 1,636 | 1,673 | 1,146 | 2,576 | 2,442 | 1,110 | 1,687 | 1,114 | — | — | — | — | — | — | — | — | — |
| Receivables | US$ in thousands | 202,657 | 211,949 | 213,534 | 201,485 | 206,562 | 211,611 | 174,249 | 177,117 | 179,142 | 181,100 | 171,532 | 146,463 | 159,376 | 154,980 | 141,305 | 132,908 | 127,555 | 146,939 | 141,533 | 141,094 |
| Total current liabilities | US$ in thousands | 578,113 | 253,233 | 273,946 | 260,076 | 300,383 | 261,755 | 264,215 | 236,939 | 251,816 | 226,889 | 262,175 | 180,487 | 442,266 | 355,411 | 288,470 | 228,339 | 253,495 | 194,384 | 338,568 | 407,827 |
| Quick ratio | 0.88 | 2.10 | 1.87 | 2.11 | 1.29 | 1.55 | 2.00 | 1.96 | 1.85 | 1.79 | 1.58 | 2.00 | 0.95 | 1.10 | 1.16 | 1.34 | 1.26 | 1.73 | 1.24 | 1.02 |
March 31, 2025 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($306,763K
+ $—K
+ $202,657K)
÷ $578,113K
= 0.88
The quick ratio of Haemonetics Corporation has shown fluctuations over the given periods, ranging from 0.88 to 2.11. A quick ratio above 1 indicates the company has sufficient liquid assets to cover its current liabilities.
Haemonetics' quick ratio stayed relatively stable around 1.2-1.4 from June 2020 to March 2021, suggesting a healthy liquidity position. However, there was a significant increase in the quick ratio to 2.00 by June 2022, indicating a substantial improvement in the company's ability to meet its short-term obligations using its most liquid assets.
Subsequently, there were fluctuations in the quick ratio, with values ranging from 0.95 to 2.00 until March 2025. The ratio dropped to 0.88 by March 2025, indicating a potential liquidity strain or a decrease in liquid assets relative to current liabilities.
Overall, the quick ratio analysis suggests that Haemonetics Corporation has experienced varying levels of liquidity strength in meeting its short-term financial obligations over the given time period, with notable fluctuations in its ability to cover current liabilities with its quick assets.
Peer comparison
Mar 31, 2025